Efficacy and Safety of Oral Budesonide in Patients with Active Crohn's Disease in Japan: A Multicenter, Double-Blind, Randomized, Parallel-Group Phase 3 Study.
Inflammatory intestinal diseases（2018）
摘要
Budesonide is comparably effective to mesalazine in the treatment of Japanese patients with mild-to-moderate active CD.
更多查看译文
关键词
Budesonide,Crohn's disease,Efficacy,Japan,Mesalazine
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要